Exercise Intensity in a Patient Taking a Beta-Blocker with Type 2 Diabetes
Mr. Delgado is a 63-year-old former bus driver in week 10 of your outpatient cardiac rehabilitation programme after an uncomplicated ST-elevation myocardial infarction treated by PCI to the left anterior descending artery (ejection fraction 42%). His medications are metoprolol succinate 100 mg daily, aspirin, atorvastatin, metformin and empagliflozin; his most recent HbA1c was 8.1%. Resting heart rate is 58 bpm and blood pressure 118/72 mmHg. On a six-minute walk test last week he covered 410 m, stopping because of breathlessness rather than leg fatigue; his heart rate rose only from 58 to 74 bpm and he rated the effort 15 on the 6-20 Borg scale. He has read on a fitness website that he should be training at 140 bpm and wants to 'push harder'. He also reports that two days ago he became shaky and sweaty about 40 minutes into a session and had to sit down; he had eaten lunch two hours earlier.
1. Explain why the 140 bpm target is inappropriate for him and describe how you would set and monitor intensity instead.
Read the worked answer
Why the heart-rate target fails here
- Metoprolol 100 mg blocks beta-1 receptors, lowering resting heart rate and blunting the rise with exercise. His heart rate moved only 16 bpm (58 to 74) during a test that stopped him with breathlessness - a flat chronotropic response consistent with substantial beta-blockade.
- Age-predicted maximum (220 minus 63, about 157) and Karvonen or percentage-of-maximum methods assume an intact chronotropic response. For him they misclassify intensity: 140 bpm may be at or beyond what he can actually reach, so he will either conclude he is not working hard enough and chase the number to exhaustion, or never reach it and lose confidence.
- The number also ignores his ejection fraction of 42% and the fact that breathlessness, not leg fatigue, ended his walk test.
What to use instead
- Effort as the primary anchor: Borg 6-20 rating of 11-13 for the next four weeks, progressing to 13-15 if symptoms allow; confirm with the talk test - he should be able to speak in sentences.
- Dyspnoea (0-10) as a second anchor, since breathlessness is his limiting symptom.
- Where available, a cardiopulmonary exercise test gives the heart rate at ventilatory threshold and at ischaemia; prescribe from that measured heart rate, not from a formula.
- Treat heart rate as a trend, not a target: does it rise with workload and fall in recovery?
- Agreed stopping criteria: chest pain, disproportionate breathlessness, dizziness, SpO2 below 90%, a sustained arrhythmia, or an unusual fall in blood pressure.
Explain to him plainly that with his medication the monitor is a guide and his effort rating is the prescription.
2. Interpret the episode of shaking and sweating and set out the changes you would make to his programme and education.
Read the worked answer
Interpretation Shaking and sweating 40 minutes into a session in a man on metformin and empagliflozin with an HbA1c of 8.1% is hypoglycaemia until proven otherwise. Arrhythmia, exertional hypotension and dehydration are possible alternatives, but the timing and symptom cluster fit low glucose best.
Two features specific to him matter:
- Beta-blockade blunts the adrenergic warning signs - palpitations, tremor, anxiety - so his only reliable early signal may be sweating, which is cholinergic and not blocked. Teach him that sweating alone means 'check glucose now'.
- The SGLT2 inhibitor causes osmotic diuresis, and exercise increases insulin-independent glucose uptake for up to 24-48 hours, so late post-exercise and nocturnal hypoglycaemia are real risks.
Changes
- Capillary glucose before, at 30-40 minutes, at the end, and at bedtime on training days; keep a written log so the pattern is visible.
- If pre-exercise glucose is under 5.5 mmol/L, take 15-20 g of carbohydrate before starting. He should carry 15-20 g of fast-acting carbohydrate and a meter to every session.
- Keep sessions to 30-40 minutes until the pattern is clear, and add a snack if a session will exceed 45 minutes.
- Avoid exercising within an hour of a rapid-acting insulin dose or at its peak action.
- Teach the 15-15 rule for treatment, and make sure he can recognise and manage an episode alone as well as with supervision.
Communication Record the episode, your interpretation, the education given and his understanding, and inform the cardiologist and diabetes team so the medication timing can be reviewed. Also check the exercise prescription is not exceeding his current capacity: breathlessness at Borg 15 on a 410 m walk suggests the session dose should be built from the six-minute walk result rather than from a heart-rate number.